CSIR’s indigenously developed Paracetamol announced by Dr Jitendra Singh

Addressing the 40th Foundation Day of the Department of Scientific and Industrial Research at Dr Ambedkar International Centre here, Union Minister Dr Jitendra Singh, Minister of State (Independent Charge) for Science and Technology, Earth Sciences (Independent Charge), MoS PMO, DoPT Personnel, Public Grievances and Pensions, Atomic Energy, Space, announced the indigenously developed drug Paracetamol, commonly used in pain, fever etc, by the Council of Scientific and Industrial Research (CSIR) which is affiliated to the Ministry of Science and  Technology, Government of India.

The Minister elaborated that CSIR has developed indigenous technology to produce paracetamol, a widely used pain reliever and fever reducer. This innovation aims to make India self-reliant in paracetamol manufacturing, reducing dependence on imported ingredients, he added.

Karnataka-based Satya Deeptha Pharmaceuticals will utilise this breakthrough to produce affordable paracetamol domestically. Currently, India imports the key raw materials for paracetamol from various countries. Thus the CSIR initiative not only addresses this dependency but also aligns with the Atmanirbhar Bharat (self-reliant India) vision.

Towards the conclusion of his speech, Dr Singh emphasised that it is high time for us to look beyond government resources for innovation and we should start exploring non-government funds along with Knowledge partnership and resource sharing. He underlined that Anusandhan NRF is a Step in the same direction where 60 per cent of the funds will be raised by non-government sectors. he reaffirmed to the scientific community that 2025 will also be a power-packed year for science and technology with innumerable ventures coming up.

The DSIR Foundation Day marked 16 more technology transfers: 9 CSIR-CSIO Chennai and 6 from CSIR-CEERI, Pilani the technology transfer between CSIR and MSME units registered under Laghu Udyog Bharati under the campaign 100 days 100 technology program.

Related Posts

Zydus Lifesciences Q4FY26 net profit rises 9%

Zydus board approved a buyback of up to Rs 1100 crore at Rs 1,150 per share, along with a 100 percent dividend for FY26. Zydus Lifesciences reported a rise in…

Chemists strike on May 20: Reasons behind today’s all-India strike

While major pharmacy chains and government medical outlets will remain operational, the strike highlights significant tensions within the industry that could impact access to medications nationwide. The All India Organisation…

Leave a Reply

Your email address will not be published. Required fields are marked *

You Missed

Zydus Lifesciences Q4FY26 net profit rises 9%

Zydus Lifesciences Q4FY26 net profit rises 9%

Chemists strike on May 20: Reasons behind today’s all-India strike

Chemists strike on May 20: Reasons behind today’s all-India strike

AbbVie loses patent plea for Hep C drug

AbbVie loses patent plea for Hep C drug

GSK’s Calpol a well-known trademark: High Court

GSK’s Calpol a well-known trademark: High Court

3 arrested for allegedly posing as doctors using forged MBBS degrees

3 arrested for allegedly posing as doctors using forged MBBS degrees

Commissioner FDA reviews enforcement measures

Commissioner FDA reviews enforcement measures